Eftrenonacog alfa (haemophilia B) – Benefit assessment according to §35a Social Code Book V

Report documents

1. Extract of dossier assessment

   Eftrenonacog alfa (haemophilia B) – Benefit assessment according to §35a Social Code Book V

   published on

   02.11.2023

   Document type

   PDF document, 295 kB, EN, not accessible

   Download file : Extract of dossier assessment (PDF document, 295 kB, EN, not accessible)
2. Dossier assessment

   Eftrenonacog alfa (haemophilia B) – Benefit assessment according to §35a Social Code Book V

   published on

   02.11.2023

   Document type

   PDF document, 440 kB, DE, not accessible

   DOI-Link

   https://doi.org/10.60584/A23-77

   Download file : Dossier assessment (PDF document, 440 kB, DE, not accessible)

Dossier assessment

Project details

Project no.

A23-77

Commission

Commission awarded on 01.08.2023 by the Federal Joint Committee (GBA).

Report type

Dossier assessment

Status

Commission completed

Department/Division

Drug Assessment

Topic

Haematology

Note

After completion of the assessment by IQWiG the Federal Joint Committee (GBA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the GBA website.

DOI

https://dx.doi.org/10.60584/A23-77

Connected Projects

1. Dossier assessment

   Eftrenonacog alfa - Assessment according to § 35a (para. 1, sentence 10) Social Code Book V

   Project no.

   G16-06

   Last updated

   15.12.2016

   Status: Commission completed